Mersana Therapeutics Alternatives & Competitors
12 companies similar to Mersana Therapeutics — Our mission is to discover and develop life-changing antibody-drug conjugates (A...
Companies similar to Mersana Therapeutics
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
Newcastle Upon Tyne, Unit...
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Prelude Therapeutics
Precision Oncology, Redefined.
Wilmington, United States
Rival Readout
Competing with Mersana Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
Germany
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
London, United Kingdom
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Alentis Therapeutics
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Allschwil, Switzerland
About Mersana Therapeutics
Mersana Therapeutics, founded in 2001, is a visionary player in the Biotechnology and Health Care sectors, headquartered in the United States. With its mission, "Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer," the company stands at the forefront of dev...
Drug Development, Clinical Trials, Patient Resource Support
Patients with cancer, Healthcare providers, Pharmaceutical partners, Researchers
Antibody-Drug Conjugates (ADCs), Cancer Research, Oncology Drug Development, Bioconjugation, Cytotoxic Therapeutics, Immunostimulatory Therapeutics, Biodegradable Polymer Platform, B7-H4 Targeting, HER2 Targeting, Clinical-Stage Biopharmaceuticals
B2B
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Mersana Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Mersana Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
